Altermune Technologies
Irvine · Founded 2010
About Altermune Technologies
Altermune Technologies LLC, a newly formed company focused on the development of novel therapeutics to combat resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic influenza. The company is led by a team of in-house scientists, and a wide network of partnerships, including collaborative research arrangements with a number of universities in the USA and Europe and corporate relationships with companies in oligonucleotide synthesis and aptamer selection.
Company Facts
- Founded: 2010
- Legal name: Altermune Technologies LLC
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Funding stage: Seed
- Last round: Seed (Sep 2011)
Canonical: https://fsome.com/organization/altermune-technologies-8338597 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.